Traws Pharma, Inc. Operating Lease Liability
Traws Pharma, Inc. (TRAW) had Operating Lease Liability of $0 as of 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2020-05-15
- 2020-03-31: Operating Lease, Liability $0.00.
- 2019-09-30: Operating Lease, Liability $0.00.
- 2019-06-30: Operating Lease, Liability $0.00.
- 2019-03-31: Operating Lease, Liability $0.00.
| Period end | Operating Lease, Liability |
|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 |
| 2019-01-01 | $0.00 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |